Quinapril
Quinapril is an ACE inhibitor used to treat high blood pressure and heart failure.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 16 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Do not take quinapril during the second or third trimester of pregnancy. Quinapril — like all ACE inhibitors — can seriously injure or kill a developing baby when taken during pregnancy. If you find out you are pregnant while taking quinapril, stop it as soon as possible and contact your doctor right away. These risks are greatest in the second and third trimesters.
📖 Quinapril: Patient Information Guide
A plain-language walkthrough of Quinapril — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Quinapril tablets are approved for two main uses:
- High blood pressure (hypertension): Quinapril tablets lower blood pressure, reducing the risk of stroke and heart attack. They can be used alone or combined with a thiazide diuretic when blood pressure isn't controlled with one medication.
- Heart failure: Quinapril tablets are used as adjunctive (add-on) therapy in heart failure, alongside conventional treatments such as diuretics and/or digitalis.
⚙️How it works▾
Quinapril is converted in the body to its active form, quinaprilat, which blocks an enzyme called ACE (angiotensin-converting enzyme). ACE normally produces angiotensin II — a chemical that constricts blood vessels and raises blood pressure. By blocking this step, quinapril keeps blood vessels relaxed, reduces blood pressure, and eases the heart's workload. It also lowers aldosterone, a hormone that makes the kidneys hold onto salt and water, which can modestly raise potassium levels.
Quinapril works in people with both high- and low-renin hypertension, although it tends to be somewhat less effective as a single agent in Black patients compared to non-Black patients.
💊How it's taken▾
Quinapril tablets are taken by mouth. For high blood pressure, they are typically taken once daily, though twice-daily dosing may be used if needed for better blood pressure control throughout the day. For heart failure, dosing generally starts twice daily and is increased gradually over weeks under medical supervision.
- High-fat meals can moderately reduce absorption — try to be consistent with when and how you take the tablet
- Your doctor will adjust the dose based on your blood pressure response and kidney function
- If you miss a dose, take it as soon as you remember — but skip it if it's almost time for the next dose. Never double up.
🤒Side effects — in detail▾
Most side effects with quinapril are mild and temporary. Common ones include:
- Dizziness or lightheadedness (especially when standing up quickly)
- Headache
- Dry, persistent cough — a well-known effect of ACE inhibitors
- Fatigue
- Nausea or vomiting
- Low blood pressure (more common in heart failure)
- Chest pain (in heart failure patients)
- Diarrhea
More serious reactions — including severe swelling of the face, lips, tongue, or throat (angioedema), sudden sharp drop in blood pressure, or signs of kidney or liver problems — require immediate medical attention. Stop quinapril and seek emergency care if swelling affects your throat or breathing.
⚠️Warnings & precautions▾
- Fetal harm: Quinapril must not be used during the second or third trimester of pregnancy. It can cause serious injury or death to an unborn baby. Stop it immediately if you become pregnant and contact your doctor.
- Angioedema (dangerous swelling): Swelling of the face, lips, tongue, throat, or intestines can occur. Throat swelling can block the airway — this is a medical emergency. Black patients have a higher reported rate of this reaction with ACE inhibitors.
- Low blood pressure: Risk is highest in people who are dehydrated, on diuretics, or have heart failure. Dizziness or fainting — especially when standing — should be reported to your doctor.
- Kidney function changes: Quinapril can reduce kidney function, especially in people already on diuretics. Blood and urine tests are recommended during treatment.
- High potassium (hyperkalemia): Quinapril can raise potassium levels, which can affect heart rhythm. Avoid potassium supplements or salt substitutes without your doctor's guidance.
- Rare liver reaction: A syndrome of jaundice progressing to serious liver damage has been reported rarely with ACE inhibitors. Contact your doctor immediately if you develop yellowing of the skin or eyes.
🔀What it interacts with▾
Quinapril can interact with several medications and substances — always tell your prescriber and pharmacist everything you take:
- Diuretics (water pills): Can cause a sharp drop in blood pressure when starting quinapril — your doctor may adjust or pause the diuretic first
- Potassium-sparing diuretics or potassium supplements: Combined with quinapril, these can raise potassium to dangerous levels
- Lithium: Quinapril can cause lithium to build up in the blood, increasing toxicity risk — close monitoring required
- NSAIDs (ibuprofen, naproxen, COX-2 inhibitors): Can blunt quinapril's blood pressure effect and increase risk of kidney problems
- Aliskiren: Should not be combined with quinapril in people with diabetes; avoid in kidney impairment
- Sacubitril/valsartan (Entresto): Do not take within 36 hours of switching to or from this drug — risk of serious angioedema
- mTOR inhibitors (e.g., temsirolimus): May increase the risk of angioedema
- Injectable gold (sodium aurothiomalate): Rare flushing, nausea, and low blood pressure reactions reported
- Tetracycline antibiotics: Quinapril's magnesium content can reduce tetracycline absorption by up to 37% — take them apart in time
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your doctor if you have ever had angioedema (severe swelling), from any cause — your risk may be higher
- Tell your doctor if you have kidney disease — quinapril is cleared through the kidneys, and doses are adjusted based on kidney function
- Tell your doctor if you have alcoholic cirrhosis or liver disease — quinapril may not be converted to its active form as effectively
- Older adults (65 and older) may have reduced kidney clearance of quinapril and typically start on a lower dose
- Do not use during pregnancy — particularly the second and third trimesters; can cause serious fetal harm or death
- Patients with collagen vascular diseases (such as lupus or scleroderma) and kidney disease may need periodic white blood cell monitoring
- People with heart failure, low sodium levels, or those on high-dose diuretics need close monitoring when starting quinapril
- Do not use if you are allergic to quinapril or have had angioedema from any ACE inhibitor
🚑If you take too much▾
Taking too much quinapril would most likely cause a serious drop in blood pressure, leading to dizziness, weakness, or fainting. There is no specific antidote, but the main treatment is supportive — lying flat and, if needed, receiving intravenous fluids (salt solution) to stabilize blood pressure. Hemodialysis does not significantly remove quinapril from the body.
📡Pharmacodynamics — effects in the body▾
Quinapril begins lowering blood pressure within about 1 hour of taking a dose, with peak effects typically reached within 2 to 4 hours. With regular use, most of the blood pressure benefit for a given dose is seen within 1 to 2 weeks. The medication lowers both sitting and standing blood pressure without significantly affecting heart rate. In heart failure, quinapril reduces the resistance the heart pumps against and improves cardiac output, while also improving exercise capacity and reducing symptoms like breathlessness, fatigue, and swelling.
🔬Pharmacokinetics — how your body processes it▾
After swallowing a quinapril tablet, peak blood levels appear within about 1 hour. The body converts quinapril into its active form, quinaprilat, which reaches peak levels roughly 2 hours after the dose. Absorption can be reduced by about 25–30% if taken with a high-fat meal. Quinaprilat is cleared mainly through the kidneys, and its removal slows significantly in people with reduced kidney function or in older adults — which is why dose adjustments are needed in those groups. About 97% of the drug circulates bound to proteins in the blood.
📦How to store it▾
Dispense in well-closed containers as defined in the USP. Store at 20° to 25°C (68° to 77°F) . Protect from light.
📄 Written from Quinapril’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Quinapril
166 supplements and herbal products have documented interactions with Quinapril in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 6
- Moderate · 136
- Minor · 24
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Quinapril has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Quinapril — the kind of thing our pharmacy team would talk through with you at the counter.
What exactly is quinapril used for? ▾
I've heard ACE inhibitors cause a cough. Is that true with quinapril? ▾
What side effects should make me call my doctor right away? ▾
Can I take ibuprofen or other pain relievers while on quinapril? ▾
Is it safe to take quinapril if I might get pregnant or if I'm already pregnant? ▾
Are there foods or supplements I need to avoid while on quinapril? ▾
Is Quinapril available over the counter? ▾
When was Quinapril first available? ▾
Who makes Quinapril? ▾
💬 Answers drafted from Quinapril’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Quinapril comes
Quinapril is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Treats high blood pressure (hypertension), used alone or with a thiazide diuretic
- Used in the management of heart failure as add-on therapy with diuretics and/or digitalis
- Take by mouth once or twice daily as directed by your prescriber
- High-fat meals can reduce absorption by roughly 25–30%, so be consistent with how you take it around meals
- For heart failure, the starting dose is taken twice daily; dose is increased gradually under medical supervision
- Do not stop taking the tablet without talking to your doctor first
📊 Quinapril across the U.S. market
How Quinapril appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (4) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
🔍 Compare Quinapril products
A representative set of FDA-listed product records for Quinapril — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 10 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 40 mg | Oral | A-S Medication Solutions × 3 listings | ANDA | Find on DailyMed ↗ |
| 20 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 5 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 5 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 10 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 10 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 20 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 40 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 40 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 5 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 10 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 20 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 40 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 10 mg | Oral | Bryant Ranch Prepack × 6 listings | ANDA | View NDC → |
| 20 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 40 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 5 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 10 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 20 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 40 mg | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 5 mg | Oral | Cipla USA Inc. × 2 listings | ANDA | View NDC → |
| 10 mg | Oral | Cipla USA Inc. × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Cipla USA Inc. × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Cipla USA Inc. × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | ANDA | View NDC → |
| 5 mg | Oral | Lupin Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 10 mg | Oral | Lupin Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Lupin Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Lupin Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 40 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 40 mg | Oral | Northwind Pharmaceuticals | ANDA | View NDC → |
| 5 mg | Oral | Parke-Davis Div of Pfizer Inc × 2 listings | NDA | View NDC → |
| 10 mg | Oral | Parke-Davis Div of Pfizer Inc × 2 listings | NDA | View NDC → |
| 20 mg | Oral | Parke-Davis Div of Pfizer Inc × 2 listings | NDA | View NDC → |
| 40 mg | Oral | Parke-Davis Div of Pfizer Inc × 2 listings | NDA | View NDC → |
| 10 mg | Oral | Proficient Rx LP × 4 listings | ANDA | View NDC → |
| 5 mg | Oral | Solco Healthcare US, LLC | ANDA | View NDC → |
| 10 mg | Oral | Solco Healthcare US, LLC × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Solco Healthcare US, LLC × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Solco Healthcare US, LLC × 2 listings | ANDA | View NDC → |
| 5 1 | Oral | Solco Healthcare US, LLC | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Aarti Pharmalabs Limited | BULK INGREDIENT | View NDC → |
| 50 kg/50 kg | — | Aurobindo Pharma Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Farmhispania, S.A. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Rolabo Outsourcing S.L. | BULK INGREDIENT | View NDC → |
Showing 83 of 83 products — FDA National Drug Code Directory. See every product, package size and price: browse all 83 Quinapril NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Quinapril — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Quinapril in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Quinapril went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 35208 1 dose form · 4 strengths
-
Dose form (SCDF) Oral Tablet RxCUI 373731In current FDA listings
Look up RxCUI 35208 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Quinapril is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 16 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Proficient Rx LP is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.